3

OWNERSHIP DOCUMENT

Company: SELLAS Life Sciences Group, Inc.
Filed: March 14, 2022
Period of Report: March 14, 2022
Accession Number: 0001104659-22-033332

View Document ↗ View on SEC.gov ↗